4.3 Review

Metabolomics for early detection of drug-induced kidney injury: review of the current status

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Assay Validation for KIM-1: human urinary renal dysfunction biomarker

Shalini Chaturvedi et al.

International Journal of Biological Sciences (2012)

Article Chemistry, Medicinal

Urine Metabolites Reflect Time-Dependent Effects of Cyclosporine and Sirolimus on Rat Kidney Function

Jost Klawitter et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2009)

Review Pharmacology & Pharmacy

Omic profiling for drug safety assessment: current trends and public-private partnerships

William M. Gallagher et al.

DRUG DISCOVERY TODAY (2009)

Article Biochemical Research Methods

Normalization strategies for metabonomic analysis of urine samples

Bethanne M. Warrack et al.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)

Review Pathology

Renal toxicity of therapeutic drugs

R. John et al.

JOURNAL OF CLINICAL PATHOLOGY (2009)

Article Environmental Sciences

A Metabonomic Study on the Biochemical Effects of Doxorubicin in Rats Using 1H-NMR Spectroscopy

Jong-Chul Park et al.

JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2009)

Article Multidisciplinary Sciences

Measurement of internal body time by blood metabolomics

Yoichi Minami et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Multidisciplinary Sciences

Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites

William R. Wikoff et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Pathology

Discovery of Metabolomics Biomarkers for Early Detection of Nephrotoxicity

Kurt J. Boudonck et al.

TOXICOLOGIC PATHOLOGY (2009)

Article Urology & Nephrology

Biomarkers of acute kidney injury

Charles L. Edelstein

ADVANCES IN CHRONIC KIDNEY DISEASE (2008)

Review Pharmacology & Pharmacy

Biomarkers of acute kidney injury

Vishal S. Vaidya et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)

Article Medicine, Research & Experimental

Urinary Biomarkers for Sensitive and Specific Detection of Acute Kidney Injury in Humans

Vishal S. Vaidya et al.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2008)

Review Pharmacology & Pharmacy

Biomarkers of nephrotoxic acute kidney injury

Michael A. Ferguson et al.

TOXICOLOGY (2008)

Article Toxicology

The utility of a rodent model in detecting pediatric drug-induced nephrotoxicity

Parvaneh Espandiari et al.

TOXICOLOGICAL SCIENCES (2007)

Article Biochemistry & Molecular Biology

Polyamine analogues - an update

H. M. Wallace et al.

AMINO ACIDS (2007)

Article Pharmacology & Pharmacy

Preclinical predictors of clinical safety: Opportunities for improvement

F. D. Sistare et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)

Article Critical Care Medicine

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

Ravindra L. Mehta et al.

CRITICAL CARE (2007)

Article Pharmacology & Pharmacy

Biomarker qualification pilot process at the US food and drug administration

Federico Goodsaid et al.

AAPS JOURNAL (2007)

Article Biochemistry & Molecular Biology

Renal nucleoside transporters: physiological and clinical implications

Adam N. Elwi et al.

BIOCHEMISTRY AND CELL BIOLOGY (2006)

Review Urology & Nephrology

Metabolomics in monitoring kidney transplants

David S. Wishart

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2006)

Article Urology & Nephrology

Metabolomic study of cisplatin-induced nephrotoxicity

D. Portilla et al.

KIDNEY INTERNATIONAL (2006)

Article Urology & Nephrology

Declining mortality in patients with acute renal failure, 1988 to 2002

Sushrut S. Waikar et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)

Article Health Care Sciences & Services

Estimating the cost of new drug development: Is it really $802 million?

CP Adams et al.

HEALTH AFFAIRS (2006)

Review Urology & Nephrology

Drug-associated renal dysfunction and injury

D Choudhury et al.

NATURE CLINICAL PRACTICE NEPHROLOGY (2006)

Review Pharmacology & Pharmacy

The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements

JC Lindon et al.

PHARMACOGENOMICS (2005)

Article Medicine, General & Internal

Acute renal failure in critically ill patients - A multinational, multicenter study

S Uchino et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)

Review Cell Biology

Polyamines and apoptosis

N Seiler et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2005)

Review Toxicology

Metabonomics in toxicology: A review

DG Robertson

TOXICOLOGICAL SCIENCES (2005)

Article Medicine, General & Internal

Measurement of kidney function

LA Stevens et al.

MEDICAL CLINICS OF NORTH AMERICA (2005)

Article Chemistry, Medicinal

Metabonomic deconvolution of embedded toxicity: Application to thioacetamide hepato- and nephrotoxicity

NJ Waters et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2005)

Article Medicine, General & Internal

Cholesterol emboli-induced renal failure and gastric ulcer after thrombolytic therapy

WA Hitti et al.

SOUTHERN MEDICAL JOURNAL (2005)

Review Medical Laboratory Technology

Drug-induced renal failure: a focus on tubulointerstitial disease

GS Markowitz et al.

CLINICA CHIMICA ACTA (2005)

Article Economics

The price of innovation: new estimates of drug development costs

JA DiMasi et al.

JOURNAL OF HEALTH ECONOMICS (2003)

Article Chemistry, Medicinal

NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats

AW Nicholls et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2003)

Article Chemistry, Medicinal

Metabolic profiling of chronic cadmium exposure in the rat

JL Griffin et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2001)

Article Chemistry, Medicinal

Chemometric models for toxicity classification based on NMR spectra of biofluids

E Holmes et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2000)